先达股份 (603086)

Shandong Cynda Chemical Co., Ltd.

ASH

K-Line Chart

No K-line data

Stock Details

1. Key Indicators

  • Total Shares(W): 43481.31
  • Circulating A-Shares(W): 43481.31
  • Earnings Per Share(RMB): 0.4500
  • Net Assets Per Share(RMB): 4.9701
  • Operating Revenue(W RMB): 200835.14
  • Total Profit(W RMB): 22350.38
  • **Net Profit Attributable to Parent(W RMB) **: 19588.88
  • Net Profit Growth Rate(%): 3064.56
  • Weighted Return on Equity(%): 9.4800
  • Operating Cash Flow Per Share(RMB): -0.2980
  • Undistributed Profit Per Share(RMB): 3.3322
  • Capital Reserve Per Share(RMB): 0.3536

2. Main Business

The main business covers:

  • Research, production, and sales of safe, efficient, low-toxicity, and environmentally friendly herbicides
  • Research, production, and sales of fungicides
  • Research, production, and sales of pharmaceutical and pesticide intermediates

3. Company Basic Information

  • Company Name: Shandong Cynda Chemical Co., Ltd.
  • Listing Date: 2017-05-11
  • Industry: Chemicals - Agricultural Chemicals
  • Address: Boxing County Economic Development Zone, Binzhou City, Shandong Province
  • Website: https://www.cynda.cn
  • Company Profile: On November 27, 2011, approved by the 2011 Fourth Interim Shareholders' Meeting of Shandong Cynda Chemical Co., Ltd., the company was converted from a limited company to a joint-stock company based on the audited parent company's net assets (excluding special reserves) of RMB 250,470,400 as of August 31, 2011. These assets were converted into 60 million shares at a ratio of 1:0.2396, with the excess amount of RMB 190,470,400 recorded as capital reserve. The company completed its industrial and commercial registration with the Shandong Administration for Industry and Commerce on December 22, 2011, obtaining a Business License with registration number 371625228004323 and a registered capital of RMB 60 million.

4. Top 10 Circulating Shareholders

Rank Institution Name Institution Type Shares Held (W) Percentage Held (%)
1 Wanjia CSI 2000 Index Enhanced Securities Investment Fund Class A Fund 1.90 0.00

5. Concept Sectors

  • Innovative Drugs

Remarks

  • Data update date: 2025-09-30
  • Data source: Public market information